With regards to rhabdomyolysis in the ICU patient:
a) List five causes. (20% marks)
b) What are the important features in the history and clinical examination, and what specific laboratory investigations would you request? (30% marks)
c) Outline the management. (50% marks)
a)
Causes (2 marks; 0.5 marks per cause. No additional marks for multiple causes under same heading. Examples of medications/infections etc. required for marks.)
1. Trauma - Crush injury, electrocution, extensive burns, compartment syndrome
2. Exertional - Prolonged exertion, refractory seizures, severe agitation
3. Medications - corticosteroids, statins, antipsychotics, neuroleptics
4. Toxins - methanol, ethylene glycol, barbiturates, amphetamine, MDMA, CO poisoning, cyanide, snake, spider envenomation
5. Body temperature changes - Heat stroke, malignant hyperthermia, malignant neuroleptic syndrome, hypothermia
6. Infections - Influenza A and B, coxsackievirus, Epstein–Barr virus, primary HIV, legionella
7. Rarer causes – electrolyte disturbances (hypoPO4, K, Ca, Na), endocrine (HONK etc.)
b)
Review history to identify risk factors or causes. .History of pre-existing renal injury or conditions that might predispose to acute kidney injury or conditions that might predispose to it.
History of Trauma, seizures, immobility, drug exposure, muscle pain, dark coloured urine,
Clinical examination/assessment: Muscle compartment swelling, tenderness, weakness, fever, myoglobinuria, peripheral perfusion
Laboratory Tests
Elevated CK
Renal dysfunction Cr – elevated; urea:Cr ratio may be decreased
electrolyte abnormalities (hyperkalemia, hypocalcemia, hyperphosphataemia, hyperuricemia, lactic acidosis). Elevated AG – due to phosphates and organic acids released from muscle
Further investigations will depend on need to further identify underlying cause e.g. urine drug screen, blood alcohol, glucose, TFTs etc
c)
Management (5 marks)
Stop further skeletal muscle damage
Interventions will vary depending on cause; e.g. discontinuation of medications, control agitation, treat infection, correct metabolic abnormalities, cool or warm, surgery etc
Rapidly identify life or limb-threatening complications
If compartment syndrome needs orthopaedic consultation – monitor pressures +/- decompressive fasciotomy
Treat any significant electrolyte abnormalities, e.g. hyperkalaemia or hypocalcaemia Prevent acute renal failure
Early and aggressive volume resuscitation with 0.9% N/saline. Dilutes nephrotoxins and promotes renal tubule flow. Urinary alkalization, forced mannitol diuresis and frusemide have been described; (candidates were not given marks for mentioning these or penalised for omitting them)
Renal replacement therapy: for usual traditional indications (hyperkalaemia, metabolic acidosis, volume overload and uraemia). Not advocated for myoglobin removal
Examiners Comments:
Candidates are reminded to read the question carefully; some answers included investigations such as CT scans and exploratory surgery, which are not “laboratory tests”.
Well answered overall.
a)
Though the question asked for only five causes, this table was compiled so as to accommodate a range of wacky differentials. It is pleasing to see the examiners tip their hand- they specify that only five classes of causes would yield full marks, i.e. one would score poorly if one just gave five different kinds of embolic phenomena.
Vascular causes |
|
Infectious causes |
|
Neoplastic causes |
|
Drug-related causes |
|
Idiopathic causes |
|
Congenital causes |
|
Autoimmune causes |
|
Traumatic causes |
|
Endocrine causes |
|
b)
"History and clinical examination, and what specific laboratory investigations" allocates only 10% of the mark to each aspect, which means one cannot afford to dwell too long on this answer.
c)
The best shortcut for the time-poor exam candidate is this UpToDate article.
Vanholder, Raymond, et al. "Rhabdomyolysis." Journal of the American Society of Nephrology 11.8 (2000): 1553-1561.
Bosch, Xavier, Esteban Poch, and Josep M. Grau. "Rhabdomyolysis and acute kidney injury." New England Journal of Medicine 361.1 (2009): 62-72.
Shapiro, Mark L., Anthony Baldea, and Fred A. Luchette. "Rhabdomyolysis in the intensive care unit." Journal of intensive care medicine 27.6 (2012): 335-342.
Holt, S., and K. Moore. "Pathogenesis and treatment of renal dysfunction in rhabdomyolysis." Intensive care medicine 27.5 (2001): 803-811.
Bosch, Xavier, Esteban Poch, and Josep M. Grau. "Rhabdomyolysis and acute kidney injury." New England Journal of Medicine 361.1 (2009): 62-72.
Allison, Ronald C., and D. Lawrence Bedsole. "The other medical causes of rhabdomyolysis." The American journal of the medical sciences 326.2 (2003): 79-88.
Brown, Carlos VR, et al. "Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?." Journal of Trauma-Injury, Infection, and Critical Care 56.6 (2004): 1191-1196.
Scharman, Elizabeth J., and William G. Troutman. "Prevention of kidney injury following rhabdomyolysis: a systematic review." Annals of Pharmacotherapy47.1 (2013): 90-105.
Sorrentino, Sajoscha A., et al. "High permeability dialysis membrane allows effective removal of myoglobin in acute kidney injury resulting from rhabdomyolysis." Critical care medicine 39.1 (2011): 184-186.
Tang, Wanxin, et al. "Renal protective effects of early continuous venovenous hemofiltration in rhabdomyolysis: improved renal mitochondrial dysfunction and inhibited apoptosis." Artificial organs 37.4 (2013): 390-400.
Ioannidis, Konstantinos, et al. "Safety and effectiveness of the combination acetazolamide and bicarbonates to induce alkaline diuresis in patients with rhabdomyolysis." European Journal of Hospital Pharmacy 22.6 (2015): 328-332.
Hohenegger, Martin. "Drug induced rhabdomyolysis." Current opinion in pharmacology 12.3 (2012): 335-339.